Singleton Rosalyn J, Redding Greg J, Lewis Toby C, Martinez Patricia, Bulkow Lisa, Morray Barbara, Peters Helen, Gove James, Jones Carol, Stamey David, Talkington Deborah F, DeMain Jeffrey, Bernert John T, Butler Jay C
Centers for Disease Control and Prevention, National Center for Infectious Diseases, Arctic Investigations Program Anchorage, Anchorage, Alaska 99508, USA.
Pediatrics. 2003 Aug;112(2):285-90. doi: 10.1542/peds.112.2.285.
In 1993-1996, we conducted a nested case-control study to determine risk factors for hospitalization with respiratory syncytial virus (RSV) infection among Alaska Native infants and young children. In the current study, we returned to former RSV case-patients and their control subjects during 1999-2001 to determine whether children who are hospitalized with RSV at <2 years of age are more likely to develop chronic respiratory conditions.
For each former RSV case-patient and control subject from remote villages in southwest Alaska, we reviewed medical records, interviewed parents, performed physical examinations and spirometry, collected sera, and analyzed chest radiographs. Case-patients were identified through surveillance for RSV hospitalization, and matched control subjects without lower respiratory infection (LRI)-related hospitalization were identified.
Hospitalization for RSV infection was associated with a significant increase in wheezing, LRIs, and asthma diagnosis during the first 4 years of life. The association decreased with age and was no longer significant by 5 years of age. However, hospitalization for RSV infection was associated with increased respiratory symptoms and increased chronic productive cough at 5 to 8 years of age. Children who were hospitalized with RSV were not more likely at follow-up to have allergies, eczema, or a positive family history of asthma.
Severe RSV infection in infancy may produce airway injury, which is manifested in chronic productive cough with or without wheezing and recurrent LRIs. Although the association of RSV infection with wheezing seems to be transient, children remain at higher risk for chronic productive cough at 5 to 8 years of age. RSV prevention modalities may prevent sequelae that occur early and later in childhood.
1993年至1996年,我们开展了一项巢式病例对照研究,以确定阿拉斯加原住民婴幼儿因呼吸道合胞病毒(RSV)感染住院的危险因素。在本研究中,我们于1999年至2001年回访了之前的RSV病例患者及其对照对象,以确定2岁以下因RSV住院的儿童是否更易患慢性呼吸道疾病。
对于阿拉斯加西南部偏远村庄的每一位之前的RSV病例患者和对照对象,我们查阅了医疗记录,采访了家长,进行了体格检查和肺活量测定,采集了血清,并分析了胸部X光片。通过监测RSV住院情况确定病例患者,并确定无下呼吸道感染(LRI)相关住院的匹配对照对象。
RSV感染住院与生命最初4年内喘息、LRI及哮喘诊断的显著增加相关。这种关联随年龄增长而减弱,到5岁时不再显著。然而,RSV感染住院与5至8岁时呼吸道症状增加及慢性咳痰增多相关。因RSV住院的儿童在随访时患过敏、湿疹或有哮喘家族史阳性的可能性并不更高。
婴儿期严重的RSV感染可能导致气道损伤,表现为伴有或不伴有喘息的慢性咳痰及反复的LRI。虽然RSV感染与喘息的关联似乎是短暂的,但儿童在5至8岁时患慢性咳痰的风险仍然较高。RSV预防措施可能预防儿童早期和后期出现的后遗症。